14-day Premium Trial Subscription Try For FreeTry Free
HK$16.60
-0.1000 (-0.599%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days HK$13.74 HK$17.02 Friday, 3rd May 2024 2696.HK stock ended at HK$16.60. This is 0.599% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.94% from a day low at HK$16.18 to a day high of HK$16.98.
90 days HK$12.20 HK$17.02
52 weeks HK$9.60 HK$17.02

Historical Shanghai Henlius Biotech Inc prices

Date Open High Low Close Volume
May 03, 2024 HK$16.18 HK$16.98 HK$16.18 HK$16.60 405 400
May 02, 2024 HK$16.34 HK$17.02 HK$16.08 HK$16.70 465 438
Apr 30, 2024 HK$16.94 HK$17.00 HK$15.82 HK$16.32 446 100
Apr 29, 2024 HK$16.36 HK$16.98 HK$15.88 HK$16.78 686 200
Apr 26, 2024 HK$16.38 HK$16.50 HK$15.90 HK$16.50 594 000
Apr 25, 2024 HK$15.74 HK$16.48 HK$15.40 HK$16.34 466 100
Apr 24, 2024 HK$15.26 HK$15.84 HK$15.10 HK$15.70 583 600
Apr 23, 2024 HK$15.26 HK$15.36 HK$14.82 HK$15.26 419 700
Apr 22, 2024 HK$14.96 HK$15.36 HK$14.70 HK$15.26 749 000
Apr 19, 2024 HK$14.66 HK$15.04 HK$14.12 HK$14.82 359 900
Apr 18, 2024 HK$14.16 HK$14.80 HK$14.16 HK$14.66 161 100
Apr 17, 2024 HK$14.56 HK$14.60 HK$14.10 HK$14.56 143 000
Apr 16, 2024 HK$14.50 HK$14.78 HK$14.20 HK$14.56 262 100
Apr 15, 2024 HK$14.76 HK$15.10 HK$14.66 HK$14.74 161 800
Apr 12, 2024 HK$14.54 HK$14.80 HK$14.40 HK$14.76 193 500
Apr 11, 2024 HK$14.60 HK$14.88 HK$14.40 HK$14.68 138 200
Apr 10, 2024 HK$15.10 HK$15.18 HK$14.70 HK$14.90 242 400
Apr 09, 2024 HK$15.00 HK$15.28 HK$14.58 HK$15.10 492 100
Apr 08, 2024 HK$14.60 HK$15.20 HK$14.60 HK$15.00 335 300
Apr 05, 2024 HK$14.14 HK$14.54 HK$13.74 HK$14.54 429 900
Apr 03, 2024 HK$14.12 HK$14.18 HK$13.84 HK$14.14 145 500
Apr 02, 2024 HK$13.80 HK$14.48 HK$13.60 HK$14.30 256 700
Mar 28, 2024 HK$13.86 HK$14.16 HK$13.62 HK$13.62 176 641
Mar 27, 2024 HK$13.96 HK$13.96 HK$13.62 HK$13.86 112 200
Mar 26, 2024 HK$14.16 HK$14.16 HK$13.76 HK$13.96 105 500
Click to get the best stock tips daily for free!

About Shanghai Henlius Biotech Inc

Shanghai Henlius Biotech Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating non-hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis; HANQUYOU, a trastuzumab injection to treat breast and metastatic gastric cancer; HANDAYUAN, an adalimumab injection for t... 2696.HK Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT